Polyomavirus BK in the pathogenesis of bladder cancer.

Polyomaviruses are able to drive malignant transformation in rodent models, and have been implicated in the aetiology of a variety of human malignancies. However, the reports on this association in humans are strongly conflicting. Here we describe a renal transplant (RT) recipient with ureteral stenosis against the background of polyomavirus BK (BKV) activity. Six and a half years after transplantation, this patient developed metastasised bladder cancer. Prior to the diagnosis of cancer, atypical cells were detected in the urine that were denoted as 'decoy cells': virally infected epithelial cells that are frequently seen in the urine of RT recipients with BKV (re)activation, which may morphologically resemble malignant cells. Intriguingly, the primary urothelial carcinoma, as well as the mesenterial and two intestinal metastases, stained positive with antibodies against polyomavirus virus large T antigen protein, whereas the adjacent healthy tissue did not. This case suggests a role for BKV in the pathogenesis of bladder cancer, at least in the context of immunodeficiency.

[1]  I. T. Ten Berge,et al.  BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response. , 2012, The Netherlands journal of medicine.

[2]  I. Galed-Placed,et al.  Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma , 2011, Diagnostic cytopathology.

[3]  T. Pruett.  Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy , 2011 .

[4]  Lei Zhang,et al.  Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China: a single‐center analysis of incidence, reduction in immunosuppression and clinical course , 2010, Clinical transplantation.

[5]  M. Jiang,et al.  BK virus and human cancer: innocent until proven guilty. , 2009, Seminars in cancer biology.

[6]  P. Friend,et al.  Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation , 2008, British Journal of Cancer.

[7]  W. Sexton,et al.  Lack of BK virus DNA sequences in most transitional‐cell carcinomas of the bladder , 2007, International journal of cancer.

[8]  A. Joachimiak,et al.  Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. , 2006, Genes & development.

[9]  D. Burstein,et al.  Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals , 2006, Diagnostic cytopathology.

[10]  K. Khalili,et al.  Role of JC Virus Agnoprotein in DNA Repair , 2004, Journal of Virology.

[11]  A. Degener,et al.  Urothelial Bladder Carcinoma and Viral Infections: Different Association with Human Polyomaviruses and Papilloma Viruses , 2003, International journal of immunopathology and pharmacology.

[12]  W. Westra,et al.  Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. , 2002, Transplantation.

[13]  P. Monini,et al.  DNA rearrangements impairing BK virus productive infection in urinary tract tumors. , 1995, Virology.

[14]  S. Friend,et al.  Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein , 1990, Journal of virology.

[15]  K. Shah,et al.  High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. , 1973, The Journal of infectious diseases.